HIV/AIDS Clinical Trials

Showing 601-620 of 1,802 trials

UNKNOWNPHASE4

Sulforaphane Use to Effect Inflammatory and Metabolic Changes in Virally Suppressed HIV Patients

NCT05224492

Assess the effects of Sulforaphane supplementation in HIV patients that have achieved viral suppression.

HIV Infections

Sunshine Specialty Health Care20 participantsStarted Feb 2022

UNKNOWN

HIV Indicator Diseases in Hospital and Primary Care

NCT05225493

Patients are frequently evaluated by physicians for medical work-up of HIV indicator conditions in hospital and in primary care at the general practitioner. Testing for HIV is indicated with HIV indicator disorder but often omitted in clinical work-up. Besides the fact that HIV testing is forgotten, there are other reasons such as an underestimation of the risk of HIV in the event of indicator disorders, stigma and difficulties in discussing the test with a patient. Also and more relevant for primary care than for the hospital, practical challenges can exist for a patient to go to a laboratory, or costs are a hurdle. This project focuses on improving HIV indicator condition driven testing in different settings of the HIV epidemic, initially in the Netherlands as low HIV prevalence setting followed by an assessment of its benefit in different international settings. A specific focus will also be on the Rotterdam area in the Netherlands which has a high prevalence of undiagnosed HIV in the Netherlands. The ultimate aim is to decrease the number of undiagnosed HIV in populations, improve the 90-90-90 HIV cascade of care goals particularly its first pillar, and to help supporting the UNAIDS goal to end HIV/AIDS

HIV InfectionsPrimary Health CareAcquired Immunodeficiency Syndrome+15 more

Erasmus Medical Center1,500 participantsStarted Jan 2020

Rotterdam, South Holland, Netherlands

Sulforaphane Use to Effect Inflammatory and Metabolic Changes in Virally Suppressed HIV Patients

HIV Indicator Diseases in Hospital and Primary Care

Related Searches

Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy

EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma

D²EFT Graphical Informed Consent

A Combination HIV Prevention Strategy for Young Women at Risk for HIV

Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics ，Pharmacodynamics of Oral SHR2150 in Healthy Subjects

Trauma Informed Prevention for Substance Use and Risky Sex

An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection

" Arthrospira Platensis" as Nutrition Supplementation for Female Adult Patients Infected by HIV in Yaoundé Cameroon

Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa

Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Infected Patients

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents

Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics